Navigation Links
Survival Rate of Cancer Patients in Korea Ranked in the Top in the World
Date:2/6/2012

SEOUL, South Korea, Feb. 6, 2012 /PRNewswire-Asia/ -- As the whole world battles against cancer, the survival rate of cancer patients in Korea has shown a great improvement. Cancer is still the number one cause of death in Korea, but about half of Korean cancer patients have, in recent times, managed to survive for more than ten years, which illustrates that world class cancer treatments are available in Korea.

The Korean government recently announced that the survival rate of Korean cancer patients had improved from 59.5% in 2008 to 62.0% in 2009, while the cancer mortality rate showed a 19% decrease in 2006 and a 21% decrease in 2008. In addition, the 2011 Health Care Quality Indicators released by OECD member countries indicated that Korea excelled in the treatment of uterine cancer and that its survival rate for stomach cancer, 65.3%, well surpassed those of the USA (26%), Europe (24.9%), Japan (62.1%) and Canada (22%). In addition, the survival rate from thyroid cancer in Korea is 99.7% while that of breast cancer is 90.6%.

Similarly, Korean Ministry of Health & Welfare carried out an interim assessment of the '10-Year Plan to Conquer Cancer' and found out that the plan had exceeded its initial objective in 2011. Thus, the Ministry upgraded the survival rate target by 2015 from 54% to 67% following the deliberation by the National Cancer Management Committee. Cancer survival rate refers to the percentage of people able to survive five years after being diagnosed with and treated for cancer. It actually means the complete recovery rate.

Such excellent survival rates for Korean cancer patients have been due to the continuous efforts of the government to manage cancer and advance the medical technology. Korea has been building its reputation in robot-assisted surgery, a cutting edge cancer treatment technology, which has every year attracted many medical experts from Japan, Taiwan and many other countries to the National Cancer Center to learn the robot-assisted surgical techniques.

Proton therapy at the National Cancer Center is one of the most renowned cancer treatment techniques in Korea. Proton therapy is a type of particle therapy that uses hydrogen ions, which are 1800 times heavier than electrons. Protons accelerated by a cyclotron irradiate a human body containing cancerous tumors in order to destroy the DNA contained by these tumors.

For more information:
Please contact Yang Ji-young of the Korea Health Development Institute's Global Healthcare Business Department at+82-43-713-8248 or kknmk0612@gmail.com.


'/>"/>
SOURCE Korea Health Development Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Published in Neuro-Oncology Journal Shows Brain Tumor Eradication and Prolonged Survival in Mice Treated With Toca 511 and 5-FC
2. Phase III Data Show Bayers Investigational Compound Regorafenib (BAY 73-4506) Met Primary Endpoint Showing Statistically Significant Improvement in Overall Survival in Patients with Metastatic Colorectal Cancer Refractory to Standard Approved Thera
3. Phase 3 Data Show Bayers Investigational Compound Regorafenib (BAY 73-4506) Met Primary Endpoint Showing Statistically Significant Improvement in Overall Survival in Patients with Metastatic Colorectal Cancer Refractory to Standard Approved Therapi
4. Clinical Trials Are Key to Doubling the Survival Rate for Pancreatic Cancer
5. Studies Investigate New Methodologies to Improve Recovery and Survival Strategies for Patients Undergoing Hematopoietic Cell Transplantation
6. Survival Benefit With Syndax Pharmaceuticals Entinostat Maintained in Women with Advanced Breast Cancer
7. Updated Survival Data from Study Comparing TTF™ (Tumor Treating Fields) Therapy to Best Standard Chemotherapy for Recurrent Glioblastoma Reported at the 16th Annual Scientific Meeting of the Society for NeuroOncology
8. The Lancet Publishes Results Demonstrating XGEVA® Significantly Prolonged Bone Metastasis-free Survival in Men With Prostate Cancer
9. Health of Recipients and Quality of Donor are Greater Factors in Survival than Metabolic Factors
10. bioTheranostics CancerTYPE ID® Linked With Improved Clinical Outcome and Longer Survival
11. Phase 3 Trial of Investigational Compound Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... DUBLIN , Dec 5, 2016 ... Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, ... Companies) - Global Forecasts to 2021" report to their offering. ... , , ... reach USD 730.7 Million in 2021 from USD 574.8 Million in ...
(Date:12/5/2016)...  Sharn Anesthesia Inc. announced today that it has ... for Salter Labs.  The company also received the 2015 ... outstanding sales performance. Salter Labs is a ... including the market gold standard ECO 2 sampling ... the Parker Flex-Tip® Endotracheal Tube, which is a leading ...
(Date:12/5/2016)... and PUNE, India , December ... report by Allied Market Research, titled, "Global Cancer Biomarkers Market ... revenue of cancer biomarkers market is projected to reach $15,737 ... CAGR of 13.3% from 2016 to 2022. Omic technologies segment ... 2015 and is expected to maintain its dominance during the ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway ... now offering HIAC particle counting and sizing services for USP 788 and 789 ... the new service as a response to the needs of pharmaceutical and medical ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... 'Tis the ... disrupt daily routines. That means it's also the season when eating healthy, staying active, ... with diabetes) on schedule is harder to do. , "Shopping trips, parties and ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the only authorized OSHA Training Institute Education Center headquartered in Northern California, has ... focused on providing occupational safety and health training to public sector employees. , ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Surgery, is excited to announce the arrival of the newest Sciton laser in ... the ability to use tunable non-ablative and ablative wavelengths for exceptional results. Outperforming ...
(Date:12/5/2016)... ... 05, 2016 , ... Researchers at Johns Hopkins All Children’s Hospital want to ... Over the course of three years, researchers will study concussions and changes in brain ... equipped with special sensors, will track the location and force of the hit. The ...
Breaking Medicine News(10 mins):